semaglutide
Stop Nausea‑Induced Switches from Semaglutide to Tirzepatide
A 12-month cohort shows 35% of patients left semaglutide citing nausea despite similar weight loss, yet improved durability on tirzepatide, indicating that proactive nausea management and genotype-guided switching can prevent dropout. In my practice I have seen patients abandon an effective drug because the morning queasiness feels relentless. Understanding the